 | | FHQ | | Name: | ~{N}-[(~{E})-(4-bromophenyl)methylideneamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanamide | | Formula: | C10 H9 Br N6 O | | SMILES: | Brc1ccc(cc1)C=NNC(=O)Cc2n[nH]nn2 | | InChi: | InChI=1S/C10H9BrN6O/c11-8-3-1-7(2-4-8)6-12-15-10(18)5-9-13-16-17-14-9/h1-4,6H,5H2,(H,15,18)(H,13,14,16,17)/b12-6+ | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | ~{N}-[(~{E})-(4-bromophenyl)methylideneamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanamide |
|
 | | FHT | | Name: | [[(2~{R})-2-[(4-bromophenyl)carbonylamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoyl]amino]azanium | | Formula: | C10 H11 Br N7 O2 | | SMILES: | [NH3+]NC(=O)[CH](NC(=O)c1ccc(Br)cc1)c2n[nH]nn2 | | InChi: | InChI=1S/C10H10BrN7O2/c11-6-3-1-5(2-4-6)9(19)13-7(10(20)14-12)8-15-17-18-16-8/h1-4,7H,12H2,(H,13,19)(H,14,20)(H,15,16,17,18)/p+1/t7-/m1/s1 | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | [[(2~{R})-2-[(4-bromophenyl)carbonylamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoyl]amino]azanium |
|
 | | FHW | | Name: | (2~{R})-3-phenyl-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide | | Formula: | C10 H12 N6 O | | SMILES: | NNC(=O)[CH](Cc1ccccc1)c2n[nH]nn2 | | InChi: | InChI=1S/C10H12N6O/c11-12-10(17)8(9-13-15-16-14-9)6-7-4-2-1-3-5-7/h1-5,8H,6,11H2,(H,12,17)(H,13,14,15,16)/t8-/m1/s1 | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | (2~{R})-3-phenyl-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide |
|
 | | FHZ | | Name: | (2~{R})-3-(4-methoxyphenyl)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide | | Formula: | C11 H14 N6 O2 | | SMILES: | COc1ccc(C[CH](C(=O)NN)c2n[nH]nn2)cc1 | | InChi: | InChI=1S/C11H14N6O2/c1-19-8-4-2-7(3-5-8)6-9(11(18)13-12)10-14-16-17-15-10/h2-5,9H,6,12H2,1H3,(H,13,18)(H,14,15,16,17)/t9-/m1/s1 | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | (2~{R})-3-(4-methoxyphenyl)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide |
|
 | | KSW | | Name: | 2-methylcyclopenta-2,4-dien-1-one | | Formula: | C6 H6 O | | SMILES: | CC1=CC=CC1=O | | InChi: | InChI=1S/C6H6O/c1-5-3-2-4-6(5)7/h2-4H,1H3 | | Definition date: | 2019-06-20 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | 2-methylcyclopenta-2,4-dien-1-one |
|
 | | KYG | | Name: | (1R,2R,3S,4R,5R,6S)-4-{[(S)-[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-3,5,6-trihydroxycyclohexane-1,2-diyl bis[dihydrogen (phosphate)] | | Formula: | C9 H21 O17 P3 | | SMILES: | OP(OCC(CO)O)(=O)OC1C(O)C(C(C(C1O)O)OP(O)(O)=O)OP(=O)(O)O | | InChi: | InChI=1S/C9H21O17P3/c10-1-3(11)2-23-29(21,22)26-7-4(12)5(13)8(24-27(15,16)17)9(6(7)14)25-28(18,19)20/h3-14H,1-2H2,(H,21,22)(H2,15,16,17)(H2,18,19,20)/t3-,4+,5-,6-,7+,8+,9+/m0/s1 | | Definition date: | 2019-01-24 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | (1R,2R,3S,4R,5R,6S)-4-{[(S)-[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-3,5,6-trihydroxycyclohexane-1,2-diyl bis[dihydrogen (phosphate)] |
|
 | | KZJ | | Name: | 6-{[1-(4-cyanophenyl)-2-oxo-1,2-dihydropyridin-3-yl]amino}-N-cyclopropyl-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxamide | | Formula: | C23 H20 N8 O2 | | SMILES: | N1(C(=O)C(=CC=C1)Nc2cc(c4n(n2)c(C(=O)NC3CC3)cn4)NC)c5ccc(cc5)C#N | | InChi: | InChI=1S/C23H20N8O2/c1-25-18-11-20(29-31-19(13-26-21(18)31)22(32)27-15-6-7-15)28-17-3-2-10-30(23(17)33)16-8-4-14(12-24)5-9-16/h2-5,8-11,13,15,25H,6-7H2,1H3,(H,27,32)(H,28,29) | | Definition date: | 2019-01-28 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | 6-{[1-(4-cyanophenyl)-2-oxo-1,2-dihydropyridin-3-yl]amino}-N-cyclopropyl-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxamide |
|
 | | FJ8 | | Name: | ~{N}-[(~{E})-(4-methylphenyl)methylideneamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanamide | | Formula: | C11 H12 N6 O | | SMILES: | Cc1ccc(cc1)C=NNC(=O)Cc2n[nH]nn2 | | InChi: | InChI=1S/C11H12N6O/c1-8-2-4-9(5-3-8)7-12-15-11(18)6-10-13-16-17-14-10/h2-5,7H,6H2,1H3,(H,15,18)(H,13,14,16,17)/b12-7+ | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | ~{N}-[(~{E})-(4-methylphenyl)methylideneamino]-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanamide |
|
 | | FJB | | Name: | [[(2~{R})-2-(5-phenylpentanoylamino)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoyl]amino]azanium | | Formula: | C14 H20 N7 O2 | | SMILES: | [NH3+]NC(=O)[CH](NC(=O)CCCCc1ccccc1)c2n[nH]nn2 | | InChi: | InChI=1S/C14H19N7O2/c15-17-14(23)12(13-18-20-21-19-13)16-11(22)9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7,12H,4-5,8-9,15H2,(H,16,22)(H,17,23)(H,18,19,20,21)/p+1/t12-/m1/s1 | | Definition date: | 2018-07-10 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | [[(2~{R})-2-(5-phenylpentanoylamino)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoyl]amino]azanium |
|
 | | LR7 | | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{R},4~{R},5~{R},6~{R})-3-(hex-5-ynoylamino)-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl] hydrogen phosphate | | Formula: | C21 H31 N3 O17 P2 | | SMILES: | O=C1C=CN(C(N1)=O)C2C(C(C(O2)COP(O)(OP(=O)(O)OC3OC(CO)C(C(O)C3NC(=O)CCCC#C)O)=O)O)O | | InChi: | InChI=1S/C21H31N3O17P2/c1-2-3-4-5-12(26)22-14-17(30)15(28)10(8-25)39-20(14)40-43(35,36)41-42(33,34)37-9-11-16(29)18(31)19(38-11)24-7-6-13(27)23-21(24)32/h1,6-7,10-11,14-20,25,28-31H,3-5,8-9H2,(H,22,26)(H,33,34)(H,35,36)(H,23,27,32)/t10-,11-,14-,15+,16-,17-,18-,19-,20-/m1/s1 | | Definition date: | 2019-03-12 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3R,4R,5R,6R)-3-(hex-5-ynoylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihydrogen diphosphate (non-preferred name) |
|
 | | K6Q | | Name: | 4-[(~{E})-2-(4-fluorophenyl)ethenyl]-1-[(~{E})-prop-1-enyl]piperidine | | Formula: | C16 H20 F N | | SMILES: | CC=CN1CCC(CC1)C=Cc2ccc(F)cc2 | | InChi: | InChI=1S/C16H20FN/c1-2-11-18-12-9-15(10-13-18)4-3-14-5-7-16(17)8-6-14/h2-8,11,15H,9-10,12-13H2,1H3/b4-3+,11-2+ | | Definition date: | 2019-04-30 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | 4-[(~{E})-2-(4-fluorophenyl)ethenyl]-1-[(~{E})-prop-1-enyl]piperidine |
|
 | | K72 | | Name: | 1-[(~{E})-prop-1-enyl]-4-[(~{E})-2-[4-(trifluoromethyl)phenyl]ethenyl]piperidine | | Formula: | C17 H20 F3 N | | SMILES: | CC=CN1CCC(CC1)C=Cc2ccc(cc2)C(F)(F)F | | InChi: | InChI=1S/C17H20F3N/c1-2-11-21-12-9-15(10-13-21)4-3-14-5-7-16(8-6-14)17(18,19)20/h2-8,11,15H,9-10,12-13H2,1H3/b4-3+,11-2+ | | Definition date: | 2019-04-30 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | 1-[(~{E})-prop-1-enyl]-4-[(~{E})-2-[4-(trifluoromethyl)phenyl]ethenyl]piperidine |
|
 | | K8B | | Name: | 4-[2-(4-propan-2-ylphenyl)ethyl]-1-[(~{E})-prop-1-enyl]piperidine | | Formula: | C19 H29 N | | SMILES: | CC=CN1CCC(CC1)CCc2ccc(cc2)C(C)C | | InChi: | InChI=1S/C19H29N/c1-4-13-20-14-11-18(12-15-20)6-5-17-7-9-19(10-8-17)16(2)3/h4,7-10,13,16,18H,5-6,11-12,14-15H2,1-3H3/b13-4+ | | Definition date: | 2019-05-02 | | Last modified: | 2020-01-24 | | Release date: | 2020-01-29 | | Identifier: | 4-[2-(4-propan-2-ylphenyl)ethyl]-1-[(~{E})-prop-1-enyl]piperidine |
|
 | | AQ6 | | Name: | 4-[[4-azanyl-3-(4-cyclohexylpiperazin-1-yl)-9,10-bis(oxidanylidene)anthracen-1-yl]amino]benzoic acid | | Formula: | C31 H32 N4 O4 | | SMILES: | Nc1c(cc(Nc2ccc(cc2)C(O)=O)c3C(=O)c4ccccc4C(=O)c13)N5CCN(CC5)C6CCCCC6 | | InChi: | InChI=1S/C31H32N4O4/c32-28-25(35-16-14-34(15-17-35)21-6-2-1-3-7-21)18-24(33-20-12-10-19(11-13-20)31(38)39)26-27(28)30(37)23-9-5-4-8-22(23)29(26)36/h4-5,8-13,18,21,33H,1-3,6-7,14-17,32H2,(H,38,39) | | Definition date: | 2018-11-15 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | 4-[[4-azanyl-3-(4-cyclohexylpiperazin-1-yl)-9,10-bis(oxidanylidene)anthracen-1-yl]amino]benzoic acid |
|
 | | BS6 | | Name: | 2-methoxy-N-[2-methyl-6-(4-methylpiperazin-1-yl)-3-oxidanylidene-2,7-diazatricyclo[6.3.1.0^{4,12}]dodeca-1(12),4,6,8,10-pentaen-9-yl]benzenesulfonamide | | Formula: | C23 H25 N5 O4 S | | SMILES: | COc1ccccc1[S](=O)(=O)Nc2ccc3N(C)C(=O)c4cc(nc2c34)N5CCN(C)CC5 | | InChi: | InChI=1S/C23H25N5O4S/c1-26-10-12-28(13-11-26)20-14-15-21-17(27(2)23(15)29)9-8-16(22(21)24-20)25-33(30,31)19-7-5-4-6-18(19)32-3/h4-9,14,25H,10-13H2,1-3H3 | | Definition date: | 2019-03-06 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | 2-methoxy-~{N}-[2-methyl-6-(4-methylpiperazin-1-yl)-3-oxidanylidene-2,7-diazatricyclo[6.3.1.0^{4,12}]dodeca-1(12),4,6,8,10-pentaen-9-yl]benzenesulfonamide |
|
 | | BT0 | | Name: | 2-methoxy-N-(1-methyl-2-oxidanylidene-benzo[cd]indol-6-yl)benzenesulfonamide | | Formula: | C19 H16 N2 O4 S | | SMILES: | COc1ccccc1[S](=O)(=O)Nc2ccc3N(C)C(=O)c4cccc2c34 | | InChi: | InChI=1S/C19H16N2O4S/c1-21-15-11-10-14(12-6-5-7-13(18(12)15)19(21)22)20-26(23,24)17-9-4-3-8-16(17)25-2/h3-11,20H,1-2H3 | | Definition date: | 2019-03-07 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | 2-methoxy-~{N}-(1-methyl-2-oxidanylidene-benzo[cd]indol-6-yl)benzenesulfonamide |
|
 | | KUD | | Name: | [(1S,2R)-2-(benzenecarbonyl)cyclopentyl]acetic acid | | Formula: | C14 H16 O3 | | SMILES: | C2CCC(C(=O)c1ccccc1)C2CC(O)=O | | InChi: | InChI=1S/C14H16O3/c15-13(16)9-11-7-4-8-12(11)14(17)10-5-2-1-3-6-10/h1-3,5-6,11-12H,4,7-9H2,(H,15,16)/t11-,12+/m0/s1 | | Definition date: | 2019-01-16 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | [(1S,2R)-2-(benzenecarbonyl)cyclopentyl]acetic acid |
|
 | | KUG | | Name: | [(1R,2S)-2-(benzenecarbonyl)cyclopentyl]acetic acid | | Formula: | C14 H16 O3 | | SMILES: | C2CCC(C(c1ccccc1)=O)C2CC(O)=O | | InChi: | InChI=1S/C14H16O3/c15-13(16)9-11-7-4-8-12(11)14(17)10-5-2-1-3-6-10/h1-3,5-6,11-12H,4,7-9H2,(H,15,16)/t11-,12+/m1/s1 | | Definition date: | 2019-01-16 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | [(1R,2S)-2-(benzenecarbonyl)cyclopentyl]acetic acid |
|
 | | KXG | | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-sulfanyl-oxolan-2-yl]methyl hydrogen phosphate | | Formula: | C15 H23 N5 O13 P2 S | | SMILES: | C2(C(C(C(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)S)O)O)O2)O)O)n4c3c(c(ncn3)N)nc4 | | InChi: | InChI=1S/C15H23N5O13P2S/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(31-14)1-29-34(25,26)33-35(27,28)30-2-6-9(22)11(24)15(36)32-6/h3-6,8-11,14-15,21-24,36H,1-2H2,(H,25,26)(H,27,28)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1 | | Definition date: | 2019-01-23 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-3,4-dihydroxy-5-sulfanyltetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | | KJT | | Name: | diethyl-[6-[[2-[2-[2-[naphthalen-2-ylsulfonyl-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]amino]ethoxy]ethoxy]ethylamino]-oxidanyl-methyl]-7-oxidanylidene-1,3,4,4~{a},5,6,8,8~{a}-octahydronaphthalen-2-ylidene]azanium | | Formula: | C44 H63 N4 O6 S | | SMILES: | CC[N+](CC)=C1CCC2CC(C(O)NCCOCCOCCN(C[CH]3CCCN(C3)Cc4ccccc4)[S](=O)(=O)c5ccc6ccccc6c5)C(=O)CC2C1 | | InChi: | InChI=1S/C44H63N4O6S/c1-3-47(4-2)40-18-16-38-29-42(43(49)30-39(38)27-40)44(50)45-20-23-53-25-26-54-24-22-48(55(51,52)41-19-17-36-14-8-9-15-37(36)28-41)33-35-13-10-21-46(32-35)31-34-11-6-5-7-12-34/h5-9,11-12,14-15,17,19,28,35,38-39,42,44-45,50H,3-4,10,13,16,18,20-27,29-33H2,1-2H3/q+1/t35-,38?,39?,42?,44?/m1/s1 | | Definition date: | 2019-05-28 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | diethyl-[6-[[2-[2-[2-[naphthalen-2-ylsulfonyl-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]amino]ethoxy]ethoxy]ethylamino]-oxidanyl-methyl]-7-oxidanylidene-1,3,4,4~{a},5,6,8,8~{a}-octahydronaphthalen-2-ylidene]azanium |
|
 | | M2E | | Name: | (4-chlorophenyl)-[(3~{S})-3-oxidanylpiperidin-1-yl]methanone | | Formula: | C12 H14 Cl N O2 | | SMILES: | O[CH]1CCCN(C1)C(=O)c2ccc(Cl)cc2 | | InChi: | InChI=1S/C12H14ClNO2/c13-10-5-3-9(4-6-10)12(16)14-7-1-2-11(15)8-14/h3-6,11,15H,1-2,7-8H2/t11-/m0/s1 | | Definition date: | 2019-10-02 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | (4-chlorophenyl)-[(3~{S})-3-oxidanylpiperidin-1-yl]methanone |
|
 | | M2H | | Name: | 3,5-dimethyl-1~{H}-pyrrole-2-carbonitrile | | Formula: | C7 H8 N2 | | SMILES: | Cc1[nH]c(C#N)c(C)c1 | | InChi: | InChI=1S/C7H8N2/c1-5-3-6(2)9-7(5)4-8/h3,9H,1-2H3 | | Definition date: | 2019-10-02 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | 3,5-dimethyl-1~{H}-pyrrole-2-carbonitrile |
|
 | | M2K | | Name: | 4,5,6,7-tetrahydro-2~{H}-indazole-3-carboxylic acid | | Formula: | C8 H10 N2 O2 | | SMILES: | OC(=O)c1[nH]nc2CCCCc12 | | InChi: | InChI=1S/C8H10N2O2/c11-8(12)7-5-3-1-2-4-6(5)9-10-7/h1-4H2,(H,9,10)(H,11,12) | | Definition date: | 2019-10-02 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | 4,5,6,7-tetrahydro-2~{H}-indazole-3-carboxylic acid |
|
 | | JPE | | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-pyridin-3-yl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-oxidanyl-propanoyl]sulfamate | | Formula: | C18 H22 N8 O8 S | | SMILES: | N[CH](CO)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)nc(nc23)c4cccnc4 | | InChi: | InChI=1S/C18H22N8O8S/c19-9(5-27)17(30)25-35(31,32)33-6-10-12(28)13(29)18(34-10)26-7-22-11-14(20)23-15(24-16(11)26)8-2-1-3-21-4-8/h1-4,7,9-10,12-13,18,27-29H,5-6,19H2,(H,25,30)(H2,20,23,24)/t9-,10+,12+,13+,18+/m0/s1 | | Definition date: | 2019-03-14 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-pyridin-3-yl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-oxidanyl-propanoyl]sulfamate |
|
 | | N72 | | Name: | (2~{R})-2-[[(3~{R},4~{R},5~{S})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid | | Formula: | C11 H19 N O9 | | SMILES: | OC[CH](O)[CH](O)[CH](O)C(=O)CN[CH](CCC(O)=O)C(O)=O | | InChi: | InChI=1S/C11H19NO9/c13-4-7(15)10(19)9(18)6(14)3-12-5(11(20)21)1-2-8(16)17/h5,7,9-10,12-13,15,18-19H,1-4H2,(H,16,17)(H,20,21)/t5-,7+,9+,10-/m1/s1 | | Definition date: | 2019-11-14 | | Last modified: | 2020-01-17 | | Release date: | 2020-01-22 | | Identifier: | (2~{R})-2-[[(3~{R},4~{R},5~{S})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid |
|